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Abstract
Background: Mozambique has a generalized HIV epidemic of 13.5% among the general population. Early modeling
exercises in Mozambique estimate that key populations (KP), defined as men who have sex with men (MSM),
female sex workers (FSW), and people who inject drugs (PWID), along with their partners account for about one
third of all new infections. There is limited data describing the engagement of KP living with HIV in testing, care
and treatment services.
Methods: We conducted a secondary data analysis of HIV-positive participants in the first Bio-behavioral
Surveillance (BBS) surveys in Mozambique conducted 2011–2014 in order to assess service uptake and progress
though the HIV treatment cascade among MSM, FSW, and PWID. Unweighted pooled estimates were calculated for
each key population group.
Results: Among HIV-positive MSM, 63.2% of participants had ever received an HIV test, 8.8% were aware of their
status, 6.1% reported having been linked to care, while 3.5% initiated ART and were currently on treatment. Of the
HIV-infected FSW participants, 76.5% reported a previous HIV test and 22.4% were previously aware of their status.
Linkage to care was reported by 20.1%, while 12.7% reported having initiated ART and 11.8% reported being on
treatment at the time of the survey. Among HIV-infected PWID participants, 79.9% had previously received an HIV
test, 63.2% were aware of their HIV status, and 49.0% reported being linked to care for their HIV infection. ART
initiation was reported by 42.7% of participants, while 29.4% were on ART at the time of the survey.
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Conclusion: Among the three high risk populations in Mozambique, losses occurred throughout critical areas of
service uptake with the most alarming breakpoint occurring at knowledge of HIV status. Special attention should be
given to increasing HIV testing and linkage to ART treatment. Future surveys will provide the opportunity to
monitor improvements across the cascade in line with global targets and should include viral load testing to
guarantee a more complete picture of the treatment cascade.
Keywords: Female sex workers, Key populations, HIV treatment cascade, Men who have sex with men,
Mozambique, People who inject drugs
Background
Key populations (KP), defined as men who have sex with
men (MSM), sex workers and their clients, people who
inject drugs (PWID), people in prisons and other closed
settings, and transgender people are population groups
disproportionally infected with HIV relative to their size
due to their high-risk sexual and drug use behaviors [1,
2]. Their risk of infection is also enhanced by legal and
social environments characterized by inadequate health
services, stigma and discrimination, and human rights
violations, all contributing to low engagement with HIV
prevention, care and treatment services [1]. The HIV
epidemic among KP has potentially far reaching effects
at the population level and the World Health
Organization describes the “multiplier effect,” whereby
KP can transmit HIV to their sexual partners in the gen-
eral population, such as female sexual partners of MSM,
clients of FSW, and non-injecting sexual partners of
PWID [1]. In addition, HIV-infected pregnant and
breast-feeding women, who may themselves be KP or
sexual partners of KP, are at risk of transmitting the in-
fection on to their children [3]. For this reason, it is im-
perative to address HIV among KP given the impact of
the disease on their health status, but also the potential
impact on the health of the general population.
Mozambique has a generalized HIV epidemic, with a
prevalence in the general population of 13.5% [4]. In
Mozambique, KP are defined as MSM, female sex
workers (FSW), and PWID. Early modeling exercises
have estimated that KP and their partners account for
about one third of all new infections in Mozambique [5].
The HIV National Strategic Plans called for special sur-
veys to be conducted among these three population
groups to estimate HIV prevalence, assess risk factors
for HIV infection and estimate population size of these
key populations [6, 7]. In response, the first round of
bio-behavioral surveillance surveys (BBS) were con-
ducted between 2011 and 2014 in three urban areas in
Mozambique. To date, these surveys represent the only
available surveillance data about KP in Mozambique.
In 2015, UNAIDS launched the 2020 Fast Track
Targets by which to monitor the response to and pro-
gression of the HIV epidemic. The “90–90-90 targets”
advocate for tracking key indicators along the treatment
cascade with the goal of ending the AIDS epidemic by
2030 [8]. These ambitious targets aim to ensure that by
2020, 90% of people living with HIV (PLHIV) are aware
of their status, of which 90% are on treatment (81% of
the total), and finally 90% of them are virally suppressed
(73% of the total). These targets provide an important
benchmark by which to monitor Mozambique’s contri-
bution to the global benchmark.
In 2015, the second National AIDS Indicator Survey
(AIS), a population-based household survey that
measures key HIV indicators, was conducted in
Mozambique and provided the first nationally represen-
tative data about the engagement of the general popula-
tion across the HIV treatment cascade [4, 9]. It is
estimated that 40% of PLHIV are aware of their status,
35% are on treatment and 23% are virally suppressed;
disaggregations of this cascade by sex highlight that men
are less engaged than women at every step. These esti-
mates are well below global targets, serve as a baseline
for the general population. They also imply a worse situ-
ation for KP given the evidence that social, legal and
structural barriers to prevention, care and treatment ser-
vices severely limit the progress of KP through the cas-
cade when compared to the general population [10].
In this context, the purpose of this secondary analysis
of results from the BBS surveys is to examine available
data from the first BBS surveys for baseline estimates de-
scribing the engagement of MSM, FSW, and PWID
living with HIV in HIV testing, care and treatment ser-
vices. The results provide important information for
monitoring critical points along the cascade.
Methods
Survey design
The first round of BBS surveys among KP in
Mozambique were conducted from 2011 to 2014 in an
urban center from each of the three regions of the coun-
try – Maputo (MSM, FSW, PWID) in the south, Beira
(MSM, FSW) in the center, Nampula (MSM, FSW) and
Nampula/Nacala (PWID) in the north. Given the diffi-
culty with reaching hard-to-reach populations, the
probability-based peer-to-peer chain-referral recruitment
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methodology, respondent-driven sampling (RDS), was
implemented [11, 12]. This methodology uses the social
network size to produce weights, whereby adjusted esti-
mates are representative of the target population in the
geographical location where the survey is conducted. A
comprehensive description of the survey study design
for each survey has been previously published [13–18].
Study population
Eligibility criteria for participants in the MSM survey in-
cluded biological male sex, minimum age of 18 years old,
reported having engaged in oral or anal sex with another
male in the 12months preceding the survey. For partici-
pants in the FSW survey, eligibility criteria included bio-
logical female sex, minimum age of 15 years old, and
having received money in exchange for sex from some-
one other than a steady partner in the 6 months preced-
ing the survey. Finally, for the PWID survey, participants
were required to be at least 18 years of age and there
was no restriction related to sex. Prior to December
2013, eligibility was based upon having reported injec-
tion drug use without a prescription in the 12months
preceding the survey. However, in an effort to account
for slow recruitment patterns, this criteria was later ad-
justed to include any person who reported having ever
injected drugs without a prescription.
For all three surveys, eligible participants were re-
quired to have lived, worked or socialized in the survey
city at least during the 6 months preceding the survey
and they must have been in possession of a valid referral
coupon received from a peer; anyone reporting previous
participation in the study was excluded. Written in-
formed consent was required separately for both the be-
havioral questionnaire and biological testing; enrollment
in the study was contingent upon providing consent to
the behavioral questionnaire. For the purpose of the
present analysis, participants who did not respond to at
least 90% of the behavioral questionnaire and/or did not
consent to have an HIV test result were excluded (n = 53
MSM, n = 6 FSW, n = 47 PWID).
Recruitment period was from July to November 2011
(MSM), September 2011 to March 2012 (FSW) and Oc-
tober 2013 to March 2014 (PWID).
Study measures
The number of PLHIV was computed based on con-
firmatory central-level ELISA test results (MSM, FSW)
or by combining rapid test results for new-positives with
self-report of known-positives (PWID). The complete
questionnaires for the three have been previously [13–
15]. For the purpose of this analysis, HIV testing uptake
was assessed based on the question, “Have you been
tested for HIV?” Knowledge of seropositive status was
determined based on responses to the question, “What
do you think is your HIV status today?” Linkage to care
was assessed based on responses to the question, “Have
you seen a nurse, doctor or other health care provider for
a medical evaluation or care related to your HIV infec-
tion?” (MSM) or “Have you sought a doctor, nurse, or
other health care professional for medical examinations
or treatment for your HIV infection?” (FSW, PWID).
ART status was assessed by the question, “Have you ever
taken or are you currently taking ARTs? (Antiretrovirals
are medicines that slow the growth of the virus in HIV-
infected people and enable people with AIDS to live for a
much longer time),” whereby ART initiation and current
on treatment were coded separately.
Statistical analysis
Unweighted pooled estimates were calculated for each
area of service uptake due to the low sample size of key
populations in each survey city. There are various ap-
proaches to constructing an HIV cascade depending on
the desired outcome of interest when assessing progress
toward the Fast Track targets [10, 19, 20]. For the pur-
pose of this analysis, the total number of PLHIV was the
denominator of each step along the HIV treatment cas-
cade; viral load suppression was not assessed. This ap-
proach provides insight into infection and potential HIV
transmission. Data analysis was conducted using SAS
version 9.4 (SAS Institute, Cary, NC, USA).
Results
Recruitment
Figure 1 outlines the recruitment and analysis flow of
the surveys where 1379 MSM (447 Maputo, 581 Beira,
351 Nampula), 1234 FSW (397 Maputo, 409 Beira, 428
Nampula), and 445 PWID (319 Maputo, 126 Nampula/
Nacala) had an HIV test result. Among those, 8.3% of
MSM (n = 114), 27.5% of FSW (n = 339) and 45.8% of
PWID (n = 204) were positive for HIV and were in-
cluded in the final analysis.
Engagement in care
Table 1 outlines the engagement of HIV-positive MSM,
FSW and PWID participants in testing, care and treat-
ment services. Of the 114 MSM who tested positive for
HIV (n = 50 Maputo, n = 53 Beira, n = 11 Nampula),
63.2% (n = 72) reported ever receiving an HIV test, 8.8%
(n = 10) were aware of their status, 6.1% (n = 7) reported
having been linked care, while 3.5% (n = 4) initiated
ARTs and were currently on treatment; thus 42.9% were
not retained in treatment.
Of the HIV-infected FSW participants (n = 339), 76.5%
(n = 261) reported a previous HIV test and 22.4% (n =
76) were aware of their status at the time of the survey.
Linkage to care was reported by 20.1% (n = 68), while
12.7% (n = 43) reported having initiated ART and 11.8%
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(n = 40) reported being on treatment at the time of the
survey; thus 93.0% of FSW who initiated treatment were
retained in care at the time of the survey.
Among HIV-infected PWID participants (n = 204),
79.9% (n = 163) had previously been tested for HIV,
63.2% (n = 129) were aware of their HIV status and
49.0% (n = 100) reported being linked to care for their
HIV infection. ART initiation was reported by 42.7% of
participants (n = 87), while 29.4% (n = 60) were on ART
at the time of the survey; thus there was 69.0% treatment
retention among PWID participants.
Progress through the HIV treatment Cascade
Figure 2 displays the unadjusted pooled estimates for the
number of participants within each key population
group as they advance through the HIV treatment
cascade. Participants in all three groups fell well below
global Fast Track Targets for knowledge of HIV status:
8.8% (MSM), 22.4% (FSW), 63.2% (PWID) and currently
on treatment: 3.5% (MSM), 11.8% (FSW), 29.4% (PWID);
viral load data was not available.
Discussion
Gaps were identified throughout the HIV treatment cas-
cade for the three populations, with the largest break-
point occurring at knowledge of HIV status; all key
populations fell below the 90% target for every indicator
although this was most stark among MSM where only
8.8% had knowledge of their HIV status prior to the sur-
vey. Furthermore, results show that of the MSM, FSW
and PWID participants who were aware of their status,
only 40.0, 52.6, and 47.2%, respectively reported being
on treatment at the time of the survey. This translates to
two in five HIV-positive MSM participants, and one in
two for both HIV-infected FSW and PWID participants.
However, once initiated on ART, both MSM and FSW
were retained above the 90% target, while a laudable
achievement this only represents a small fraction of the
HIV-positive population. In general terms, use of
Fig. 1 BBS Recruitment and Analysis Flow, Mozambique 2011–2014. * Individuals who did not respond to at least 90% of the behavioral
questionnaire and/or did not consent to have an HIV test result were excluded from analysis
Table 1 Engagement in HIV Services among MSM, FSW and PWID in Mozambique, 2011–2014
MSM (N = 114) FSW (N = 339) PWID (N = 204)
Services n % n % n %
Previous HIV Test 72 63.2% 261 77.0% 163 79.9%
Knowledge of HIV status 10 8.8% 76 22.4% 129 63.2%
Linkage to HIV services 7 6.1% 70 20.6% 100 49.0%
Initiated ART Treatment 4 3.5% 43 12.7% 87 42.6%
Currently on ART Treatment 4 3.5% 40 11.8% 60 29.4%
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services appears higher among PWID, when compared
to the other KP groups; however, PWID are still well
below global targets.
When compared to other KP groups in the region,
HIV testing uptake among survey participants was con-
sistent with previous studies [21, 22]. However, MSM
and FSW surveys in Mozambique reported lower aware-
ness of their HIV status compared to those same groups
in other Sub-Saharan African countries, although PWID
participants reported higher awareness than other PWID
in the region [23–28]. ART engagement was also lower
across all populations groups [23, 27, 29, 30]. In the few
studies with results of viral load suppression in Sub-
Saharan Africa, there was a range of 11%-42 among
MSM, 11.0–49.5% among FSW and less than 5% in
among PWID in Kenya [24–28]. The differences in re-
sults may be attributed to different survey measures, re-
cruitment methodology, policies and interventions.
However, accurate and quality data examining the cas-
cade in Sub-Saharan Africa across the three population
groups is still scarce ( [27]. Nevertheless, to our know-
ledge, no countries in Sub-Saharan Africa have been able
to meet ambitious 90–90-90 Fast Track Targets for key
populations.
Mozambique’s most recent AIDS Indicator Survey, a
nationally representative household survey, was con-
ducted in 2015 and included indicators to monitor ser-
vice uptake and the treatment cascade within the
general population [4, 9]. History of HIV testing among
people living with HIV (PLHIV) in the general popula-
tion compared to HIV-infected key populations was
similar among females and lower among men: 73.6%
(females) and 55.8% (males) compared to 63.2% (MSM),
76.5% (FSW) and 79.9% (PWID). PLHIV in the general
population were much more aware of their status than
HIV-infected KP: 46.2% (females) and 28.1% (males)
compared to 8.8% (MSM), 22.3% (FSW) and 63.2%
(PWID), demonstrating major programmatic challenges
to linking these vulnerable populations to care and treat-
ment services. Although ART initiation was not assessed
in the AIS, all three KP reported lower current enroll-
ment in ART treatment than the general population:
40.0% (females) and 23.0% (males) compared to 3.5%
(MSM), 11.8% (FSW), and 29.4% (PWID), however, the
data highlights the pressing need for improved HIV
treatment services for all population groups. The results
do not include viral load estimates for KP, however
given that viral suppression among PLHIV in the general
population are greatly below global targets at 36.9%
(females) and 22.4% (males), we can assume that the
outcomes among KP are considerably lower given
their lower engagement in services compared to the
general population as well as the evidence of social,
legal and structural barriers to access health care ser-
vices [10]. The low evidence of engagement in health
services among MSM is consistent with low health
service access among men in the general population
in Mozambique [4].
Finally, the results must be understood within the
context of the care and treatment landscape when the
surveys were implemented. Mozambique’s National Ac-
celeration Plan was introduced in 2013, which changed
treatment guidelines and vastly scaled up the availability
of ART in the country. The roll-out of increased ART
Fig. 2 HIV Treatment Cascade among MSM, FSW and PWID in Mozambique, 2011–2014. PLHIV: People Living with HIV. Gaps in Target: The
baseline shortfall between service engagement and the achievement of the Fast Track Targets; viral suppression data not available
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provisions occurred after the BBS was implemented
among MSM & FSW. This change in the landscape may
explain why PWID reported greater engagement in the
care compared to the other KP groups. Despite this pol-
icy change however, there is still evidence in the most
recent AIDS Indicator Survey of low engagement of the
general population in the HIV treatment cascade, where
men are less engaged than women, and thus it can be
posited that even with greater access to ART services,
social and structural barriers continue to impact KP en-
gagement in health services.
More recent data estimate that in 2019, 77% of
PLHIV are aware of their status, 60% were on treat-
ment and 45% are virally suppressed, however viral
load testing was only available for about half of
PLHIV on treatment and therefore must be inter-
preted with caution. Viral load testing is not yet uni-
versally available due to insufficient patient/provider
demand and systemic issues such as inadequate infor-
mation flow and limited technology [31]. However,
the next round of BBS surveys will provide updated
estimates of KP engagement in the HIV testing and
treatment cascade and will include viral suppression
estimates that can provide a point of comparison with
those of the general population.
This is the first analysis of engagement in HIV ser-
vices and progress through the HIV treatment
cascade among key populations in Mozambique. Al-
though this analysis offers important insights into the
use of HIV treatment services among key populations
in Mozambique, it is important to acknowledge this
analysis’ limitations.
While RDS is a robust methodology for sampling
among hidden populations, there are some inherent
limitations such as selection bias in chain referral
sampling methods, recall bias and social desirability
bias for self-reported risk behaviors; non-response
bias also applies to individuals who did not consent
to an HIV test – and were subsequently removed
from the analysis –however the proportion was rela-
tively low (3.70% MSM, 0.24% FSW, and 9.55%
PWID). PWID population definition was modified in
the middle of recruitment due to slow recruitment
patterns, from injection in the last 12 months to ever
having injected drugs without a prescription. Only 2%
of the sample across both PWID survey cities re-
ported not injecting in the past 12 months and there-
fore this change in recruitment likely did not have a
large impact on the overall size estimation. Neverthe-
less, the change of definition may have an impact on
the comparability of the results to other populations
and future BBS surveys. Additionally, some respon-
dents may have been previously aware of their HIV
positive status but refused to disclose due to stigma
or social desirability given the common knowledge
that HIV-positive individuals should be engaged in
care and treatment. This potential selective underre-
porting of HIV status has been observed in previous
studies, and can underestimate prevalence results and
subsequent cascade assessments [24, 25, 32, 33]. As
an illustrative example, in the most recent AIS con-
ducted in Mozambique, only 26.1% of PLHIV self-
reported current ART use however, when biomarker
testing was used, the number of current on ART in-
creased to 35% indicating that individuals did not
self-disclose their status [4].
Next, the computation of unweighted pooled estimates
among survey participants means that results are not
generalizable to the KP in the geographic locations
where the surveys were conducted nor to other cities in
Mozambique, but instead only represent survey partici-
pants. Due to the low sample size, it was not possible to
conduct meaningful weighted estimates of the cascade
for the KP in each survey city. However, the results pro-
vide the best available proxy indication of engagement in
services and progress through the HIV treatment cas-
cade and highlight the need for enhanced efforts tar-
geted to these groups.
Finally, the data was collected in 2011–2014 and may
not represent the current situation of KP in the country,
however, they remain the only available surveillance data
about KP Mozambique and the best available indication
of engagement in services and progress through the HIV
treatment cascade. The continued absence of more up-
dated surveillance data limits the comprehensive moni-
toring of the HIV epidemic and demonstrates the need
to strengthen the HIV surveillance system in the
country.
Conclusions
The results of this analysis highlight the necessity for
interventions that increase uptake of HIV testing and
ART treatment among all KP, but particularly among
MSM and FSW who reported less engagement than
PWID. Since the implementation of the first round of
BBS surveys among KP in Mozambique, National
Guidelines were adopted outlining a standard package
of 10 services for KP such as HIV counseling and
testing; STI screening; and provision of condoms and
lubricants [34]. Additionally, in 2017, Mozambique
began the roll-out of the test and start strategy with
specific emphasis on individuals belonging to key
population groups.
Follow-up BBS surveys will provide important data
points to assess trends and monitor improvements in KP
engagement in the health system as a result of these pol-
icies. In addition, the inclusion of viral load testing in fu-
ture surveys will guarantee a more complete picture of
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the HIV testing and treatment cascade among popula-
tions most vulnerable to HIV transmission. In the
meantime, the results from this analysis can be applied
to size estimation exercises to support target setting and
resource allocation. Modeling exercises can also use
these and programmatic data to assess the burden of the
HIV epidemic attributable to key populations in
Mozambique. Finally, improved health information sys-
tems at the community and facility level for KP can also
provide more up to date information on their progres-
sion through the cascade.
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